Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
Fixed-dose regimes ‘modestly’ lower risk of HIV treatment failure

New research compares treatment outcomes of single versus multiple tablet regimes, raising questions around cost-effectiveness.

Published
15 December 2017
From
Avert
Shift in HIV-Associated Kidney Disease Characterized

Successful antiretroviral therapy for human immunodeficiency virus (HIV) infection has altered the spectrum of HIV-associated kidney disease over the past 30 years, according to the authors of a new review published in the New England Journal of Medicine.

Published
15 December 2017
From
Renal & Urology News
UNICEF warns, the global HIV response is failing children and adolescents

Unless the HIV response is stepped up, we will not end AIDS in children and adolescents. This is the stark message in a new UNICEF report, released earlier this month.

Published
15 December 2017
From
Avert
Almost half of under 25s 'never use a condom with a new partner'

Public Health England launches a new campaign to get more people thinking about using condoms.

Published
15 December 2017
From
BBC Health
Baseline CD4 count biggest factor in long-term immune system improvements after starting HIV therapy

Pre-treatment CD4 cell count is the most important factor in immune recovery following the initiation of combination antiretroviral therapy (cART), according to the results of a large observation

Published
14 December 2017
By
Michael Carter
The US Could Easily Hit Its 2020 HIV Prevention Goal By Using One Drug, Drexel Study Finds

If just a quarter of men who have same-sex intercourse and are at a high risk for HIV used daily preventive medicine, three out of every 10 HIV infections could be averted, according to a new Drexel University study.

Published
13 December 2017
From
Drexel Now
South Africa’s HIV treatment programme: a phoenix rising from the ashes?

In our most recent modelling study, published this week in PLoS Medicine, we have attempted to look back on what the ART programme has achieved to date – and what could have been achieved. It’s too soon to say whether progress reducing AIDS deaths has stalled, but the early signs suggest that this may be the new reality in the post-2014 period.

Published
13 December 2017
From
Ground Up
Fingerprints of Russian Disinformation: From AIDS to Fake News

Called Operation Infektion by the East German foreign intelligence service, the 1980s disinformation campaign seeded a conspiracy theory that the virus that causes AIDS was the product of biological weapons experiments conducted by the United States.

Published
13 December 2017
From
New York Times
Transition to dolutegravir cost-effective in LMICs with high HIV drug resistance

In low- and middle-income countries, resistance to non-nucleoside reverse transcriptase inhibitors, or NNRTIs, is nearing and exceeding 10% in patients with HIV who are initiating or reinitiating first-line ART, according to recent data. A new modeling study showed that transitioning first-line ART from NNRTIs to dolutegravir may be a cost-effective way to reverse this increasing trend in resistance.

Published
13 December 2017
From
Healio
Frontiers of HIV Research: The Man Who Was Nearly Cured

“The whole excitement around Clark is that we were able to initiate therapy so early that we were hoping to prevent the establishing of latency,” says Deeks. “But it did not happen. We got close; we may have been off by a day or two. We did not achieve a real cure.”

Published
13 December 2017
From
KQED
← First12345...2359Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.